| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Genetic Technologies Limited (NASDAQ: GENE)
GENE Technical Analysis
5
| As on 9th Jun 2023 GENE SHARE Price closed @ 0.98 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.56 & Strong Sell for SHORT-TERM with Stoploss of 1.94 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GENESHARE Price
| Open | 0.99 | Change | Price | % |
| High | 0.99 | 1 Day | -0.01 | -1.01 |
| Low | 0.98 | 1 Week | 0.02 | 2.08 |
| Close | 0.98 | 1 Month | 0.02 | 2.08 |
| Volume | 48000 | 1 Year | -1.06 | -51.96 |
| 52 Week High 2.23 | 52 Week Low 0.86 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| GENE Daily Charts |
GENE Intraday Charts |
Whats New @ Bazaartrend |
GENE Free Analysis |
|
|
GENE Important Levels Intraday
| RESISTANCE | 1.00 |
| RESISTANCE | 0.99 |
| RESISTANCE | 0.99 |
| RESISTANCE | 0.99 |
| SUPPORT | 0.97 |
| SUPPORT | 0.97 |
| SUPPORT | 0.97 |
| SUPPORT | 0.96 |
GENE Forecast April 2024
| 4th UP Forecast | 1.79 |
| 3rd UP Forecast | 1.53 |
| 2nd UP Forecast | 1.37 |
| 1st UP Forecast | 1.21 |
| 1st DOWN Forecast | 0.75 |
| 2nd DOWN Forecast | 0.59 |
| 3rd DOWN Forecast | 0.43 |
| 4th DOWN Forecast | 0.17 |
GENE Weekly Forecast
| 4th UP Forecast | 1.73 |
| 3rd UP Forecast | 1.49 |
| 2nd UP Forecast | 1.34 |
| 1st UP Forecast | 1.19 |
| 1st DOWN Forecast | 0.77 |
| 2nd DOWN Forecast | 0.62 |
| 3rd DOWN Forecast | 0.47 |
| 4th DOWN Forecast | 0.23 |
GENE Forecast2024
| 4th UP Forecast | 4.01 |
| 3rd UP Forecast | 3.04 |
| 2nd UP Forecast | 2.44 |
| 1st UP Forecast | 1.84 |
| 1st DOWN Forecast | 0.12 |
| 2nd DOWN Forecast | -0.48 |
| 3rd DOWN Forecast | -1.08 |
| 4th DOWN Forecast | -2.05 |
Genetic Technologies Limited ( NASDAQ USA Symbol : GENE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GENE Business Profile
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include cardiovascular, type 2 diabetes, prostate cancer, and melanoma. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia. Address: 60-66 Hanover Street, Fitzroy, VIC, Australia, 3065
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service